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Abstract
Background: Study attrition has the potential to compromise a trial’s internal and external validity. The aim of the
present study was to identify factors associated with participant attrition in a pilot trial of the effectiveness of a
novel behavioural support intervention focused on increasing physical activity to reduce smoking, to inform the
methods to reduce attrition in a definitive trial.
Methods: Disadvantaged smokers who wanted to reduce but not quit were randomised (N = 99), of whom 61
(62 %) completed follow-up assessments at 16 weeks. Univariable logistic regression was conducted to determine
the effects of intervention arm, method of recruitment, and participant characteristics (sociodemographic factors,
and lifestyle, behavioural and attitudinal characteristics) on attrition, followed by multivariable logistic regression on
those factors found to be related to attrition.
Results: Participants with low confidence to quit, and who were undertaking less than 150 mins of moderate and
vigorous physical activity per week at baseline were less likely to complete the 16-week follow-up assessment.
Exploratory analysis revealed that those who were lost to follow-up early in the trial (i.e., by 4 weeks), compared
with those completing the study, were younger, had smoked for fewer years and had lower confidence to quit in
the next 6 months. Participants who recorded a higher expired air carbon monoxide reading at baseline were more
likely to drop out late in the study, as were those recruited via follow-up telephone calls. Multivariable analyses
showed that only completing less than 150 mins of physical activity retained any confidence in predicting attrition
in the presence of other variables.
Conclusions: The findings indicate that those who take more effort to be recruited, are younger, are heavier
smokers, have less confidence to quit, and are less physically active are more likely to withdraw or be lost to follow-up.
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Background
Participant attrition within research trials poses a threat
to internal validity (attrition bias) [1], external validity
(retained participants may not reflect practice) and loss
of statistical power (reduced number of participants).
Strategies to minimise attrition, such as knowing when
and where to direct resources, may also have implica-
tions for the cost of conducting trials due to additional
researcher time necessary to capture follow-up data [2].
Pilot trials can help to identify factors associated with
study attrition and provide valuable information for the
planning of a definitive trial, such as providing options
for mode of participation (e.g. face-to-face assessments,
telephone interviews, or postal questionnaires) [3] and
identifying which participants are more likely to drop
out and when to allow effective planning to maximise
retention of participants..
It is usual for smoking cessation intervention trials to
utilise intention-to-treat (ITT) analyses with an assump-
tion that a participant lost to follow-up is still smoking
(baseline observation carried forward) [4]. This assump-
tion is problematic, as it could bias results and statistical
tests in favour of an effective treatment if attrition rates
are higher in the control group, as there is some evi-
dence to suggest that those lost to follow-up in such tri-
als may not necessarily be smoking [5–9]. Different
approaches to handling missing data on smoking status
at follow-up have been suggested, which may provide
more reliable estimates of treatment effects [10–12].
However, all approaches rely on making assumptions
about the missing data. It is therefore important to
understand the factors influencing attrition to allow for
more informed approaches to handling missing data,
and to identify ways to minimise attrition in future
smoking studies. This could be especially true of trials
involving low socioeconomic groups where attrition
rates may be greater than for other groups.
Studies involving interventions to support ‘abrupt’
smoking cessation report a wide range of attrition rates.
In a review of RCTs of individual behavioural counsel-
ling interventions for smoking cessation [13], attrition
rates (where reported) ranged from 1.7 % [14] to 22.4 %
[15] at 6 months’ follow-up and from 3 % [16] to 31 %
[17] at 12 months’ follow-up. A review of RCTs of inter-
ventions combining behavioural counselling and phar-
macological support [18] identified a range of attrition
rates from as low as 4–8 % [19] in one study and up to
24–30 % [20] in another at 6 months’ follow-up, and be-
tween 7 % [21] to 52 % [22] at 12 months’ follow-up in
two other studies. Although one study identified in the re-
view saw an attrition rate < 5 % at 24 months’ follow-up
[23] it targeted inpatients with acute coronary syndrome
who were probably more accessible for follow-up, com-
pared with participants in the community. In contrast, a
review of self-help interventions for smoking cessation
[24], representing the least intensive level of intervention,
included studies with attrition rates ranging from 11 %
[25] to 66 % [26] at 6 months’ follow-up and <10 % [27] to
56 % [28] at 12 months’ follow-up.
Despite there being 60 systematic reviews on the
Cochrane Database on the effectiveness of interventions
for smoking cessation [4], little attention has been given
to identifying the factors associated with study attrition.
The factors associated with attrition in studies concerned
with smoking reduction or involving disadvantaged
smokers [29, 30] are particularly poorly understood, due
to a small number of such studies.
A number of factors may influence attrition including:
(i) the nature of the intervention (e.g., clinical trials of
an investigational medicinal product (CTIMPs) versus
clinical trials of complex behavioural interventions (non-
CTIMPs); (ii) the population characteristics (e.g., socio-
economic status, demographics); (iii) the study design
(e.g., length of time to follow-up, burden of data collec-
tion on participant); and (iv) specifically among smoking
trials, a focus on abrupt smoking cessation versus smok-
ing reduction.
Smoking reduction is increasingly recognised as a vi-
able alternative to the traditional abrupt smoking cessa-
tion approach, with flexible outcome measures [31], and
it is unclear if there is any difference between these ap-
proaches on attrition. A review comparing interventions
involving smoking reduction or abrupt cessation [32] in-
cluded ten studies with attrition rates ranging from
19.1 % [33] to 21–24 % [34] at 6 months, and 11–13 %
[35] to 64 % [36] at 12 months but there appeared to be
no difference in attrition between those reducing their
smoking before quitting or stopping abruptly.
There have been no reports of when certain partici-
pants are likely to drop out, and given the progressive
nature of smoking cessation and reduction it is likely
certain participants may be more or less likely to with-
draw at different times (i.e., time of dropout may be pre-
dicted by baseline characteristics such as confidence and
importance to cut down or quit). Understanding these
potential predictors of when a participant is likely to
drop out would allow trialists to better plan resource use
and direct support to participants at certain times to
maximise the retention of participants.
Exercise as an aid to smoking cessation has been ac-
knowledged as a feasible intervention for supporting ces-
sation, yet the number of rigorous studies remains
limited: there were only 15 studies included in the latest
Cochrane review on the topic [37], 7 of which included
fewer than 25 participants. Of the studies identified in
this review, attrition rates varied from 0.3 % [38] to
60.8 % [39] at 6 months and from 0.5 % [40] to 68–75 %
[41] at 12 months. The heterogeneity of research designs
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and methods among these studies makes it difficult to
identify any factors associated with attrition, but attrition
rates seem high compared with other studies involving
interventions for smoking cessation.
Other studies which present attrition rates from smok-
ing cessation studies with specific populations also present
similar attrition rates to the smoking studies more gener-
ally. A study on exercise and counselling for smoking ces-
sation for those with current depressive disorders reports
attrition rates of 20 % and 37 % for the intervention and
control respectively [42]. Another exercise counselling for
smoking cessation among depressed women [43] reports
slightly higher attrition rates of 35 % at 10 weeks with no
difference between arms. A recent study using exercise to
support pregnant smokers to quit reported 11 % attrition
for unexplained reasons [44]. A study supporting home-
less people to quit [45] reports 25 % attrition at 26 weeks
with no difference between study arms. As with the
broader smoking cessation literature, the reported cessa-
tion rates among specific populations are varied and
within similar ranges, suggesting specific characteristics
may not impact on overall attrition rates.
There are few studies on the effectiveness of interven-
tions for smoking cessation among low socioeconomic
groups. In a recent review of low-income groups and
health-behaviour change interventions [46] only 13 stud-
ies were identified, and of those only 7 targeted smoking
behaviour, and no studies examined potential predictors
of and reason for study attrition. None of the identified
studies focused on smoking reduction among low socio-
economic groups.
Some authors suggest that attrition rates are generally
higher in the control condition [10–12], but in the litera-
ture we reviewed some studies showed greater attrition
in the control or intervention arm, and the majority
showed no difference between trial arms. A meta-
analysis of a random sample of 100 randomised con-
trolled trials (RCTs) published in medical journals (with
a range of participants and interventions) also showed
no differential attrition between intervention and control
conditions [47].
Several factors have been associated with increased
attrition in smoking trials among various populations,
including a higher Fagerström Test for Nicotine De-
pendence (FTND) score [48], a lower intention to quit
[49], low self-efficacy and a longer smoking history
[25], and the number of cigarettes smoked per day
[50–52]. It is commonly believed that attrition within
smoking cessation studies is driven by failure to main-
tain a successful quit attempt, where the individual will
no longer seek support once they have reinitiated
smoking as it holds no value if they are smoking again.
This could be why factors associated with failing to
quit (such as level of addiction and dependence) are
related to attrition. Less is known in relation to failure
to reduce as a predictor of attrition.
The aim of this study is to identify the factors associated
with participant attrition in a pilot RCT on the effective-
ness of a novel Exercise-Assisted Reduction then Stop
(EARS) intervention (HTA number 07/78/02, ISRCTN
13837944, UKCRN Study ID 8937) among disadvantaged
smokers. EARS recruited a disadvantaged population
assessed by predetermined criteria (e.g., 91 % were social
class C2-E and 41 % indicated mental health problems),
the details of which have been published elsewhere [53].
The specific objectives of this study are to determine if
features of the trial design and methods, and participant
characteristics, are associated with participant attrition, to
inform the design and methods for a definitive trial.
Methods
Participants
Ethical approval for the study was granted by the Na-
tional Health Service (NHS) National Research Ethics
Service Committee South West, in the UK. Recruitment
took place in the neighbourhoods of Devonport and
Stonehouse (Plymouth, UK), which are among the 3 %
most deprived areas in the UK. The recruitment methods,
factors influencing recruitment, and baseline characteris-
tics of the sample, have been reported elsewhere [54]. In
summary, 99 adult moderate to heavy smokers, who
wanted to reduce smoking (without nicotine replacement
therapy (NRT)) but had no plans to quit in the next
month, were recruited by either a mailed invitation from
their general practitioner or NHS Stop Smoking Services
(SSS), with follow-up telephone calls, or through other
community approaches.
Procedures
After providing informed consent and baseline informa-
tion, participants were randomised to receive either
usual care (consisting of brief advice on smoking cessa-
tion services) or usual care plus the EARS intervention
(consisting of up to 12 weekly client-centred individual
support sessions, via telephone or in person, to assist
with making self-directed changes in smoking and phys-
ical activity behaviour). Participants in either arm of the
trial expressing the desire to quit were offered the
chance to be referred to local SSS for specialist support.
Follow-up assessments were completed at 4, 8, and
16 weeks post-randomisation. For those who missed
follow-up appointments, up to five attempts were made by
telephone to reschedule the appointment; the rescheduled
appointment could take place up to the halfway point be-
tween the missed appointment and the next follow-up.
After the halfway point attempts were made to schedule
the next follow-up appointment. Those who could not be
contacted at all were classified as having dropped out of
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the study. Reasons for withdrawal were recorded for those
who explicitly withdrew consent to participate in the study.
Measures
At baseline the following data were collected: participant
demographic information (i.e., age, sex, marital status,
cohabiting with other smokers, parental status (single
parent living with a dependent under 16 years of age),
employment status (employed or not), job status (social
class), age of leaving full-time education, ethnicity, weight,
and height), smoking history (age participant started
smoking, longest period of cessation in the last year, at-
tempts at cutting down, cessation aids used in the past
year, use of SSS), number of cigarettes being smoked per
day, Fagerström Test for Nicotine Dependence (FTND;
[55, 56]) scores, stage of readiness to use physical activity
to control smoking behaviour, expired air carbon mon-
oxide (CO), and physical activity data (subjectively by
self-report of the previous 7 days and objectively by ac-
celerometer). Follow-up assessments captured data on
smoking- and physical activity-related behaviours and
attitudes. In order to ensure compliance with wearing
and returning accelerometers (costing approximately
£250 each) we initially paid participants £10 for return-
ing the accelerometer at each time point (except week
4 when they were not worn). This was increased to £30
at each time point when it was observed a considerable
number had not been returned about a third of the way
through the study. No other payment was made to par-
ticipants for completing assessments other than reim-
bursing travel expenses. For the purposes of the present
study, those lost to follow-up before the final follow-up
(week 16) was the primary binary outcome. We also
classified participants as dropping out early or late:
early dropouts were those who did not complete any
assessment after baseline, and late dropouts were those
who failed to complete follow-up assessments after
week 4. Field notes were maintained to capture qualita-
tive reasons for attrition as reported by withdrawing
participants and as observed by researchers.
Data analysis
To determine the factors associated with study attrition at
16 weeks, binary logistic regression was performed and
odds ratios (OR) reported with 95 % confidence intervals
(95 % CI). Intervention arm, method of recruitment, par-
ticipant demographics, and lifestyle, behavioural, and
attitudinal characteristics were individually examined as de-
terminants of attrition, based on existing literature and the
researchers’ a priori reasons for their inclusion. Following
the univariable analyses, each significant predictor of attri-
tion was then added to multivariable logistic regression.
Further exploratory analysis sought to compare those who
dropped out earlier (before week 4), later (after week 4), or
completed the study. Attrition status (early dropout, late
dropout or completion) was analysed using multinomial lo-
gistic regression, with inclusion of each covariate individu-
ally in a separate univariable model, followed by the
inclusion of the variables related to attrition in a multivari-
able multinomial logistic regression model. Multinomial
logistic regression was chosen in place of ordinal logistic re-
gression as the three categories were considered to be
qualitatively different and not necessarily sequential.
Additional exploratory analyses examined change in
cigarettes smoked per day (and therefore the success of
individual change) as a predictor of dropout. For those
who were followed up at least once post baseline, two
categorical variables of at least a 50 % reduction and any
positive reduction from baseline to week 4 and week 8
were coded and analysed through univariable binary
logistic regression in relation to drop out before week16.
All statistical analyses were completed using Stata SE
(v. 12.0) (StataCorp LP, College Station, TX, USA).
Results
The overall sample characteristics for the 99 participants
recruited and randomised have been reported elsewhere
[49]. Data were collected from 61.6 % (n = 61) at
16 weeks post baseline. Study attrition occurred primar-
ily soon after baseline with 21 of the 38 participants lost
to follow-up not completing the week 4 assessment.
Table 1 shows that for the sample as a whole those
with high self-reported confidence to quit in the next
6 months (n = 48) were less likely to be lost to follow-up
than those with low confidence. Also, those completing
at least 150 mins of moderate and vigorous physical ac-
tivity (MVPA) per week (n = 69) were also less likely to
be lost to follow-up.
The multivariable binary logistic regression of vari-
ables found to be related to attrition in the univariable
analyses Revealed that in the presence of other variables,
only the completion of 150 mins of moderate and vigor-
ous physical activity (MVPA) per week or more was re-
lated to a lower odds ratio of being lost to follow-up
(OR (95 % CI) 0.32 (0.13; 0.80)). Confidence to quit in
the next 6 months was not related to lower odds of be-
ing lost to follow-up (OR (95 % CI) 0.43 (0.18; 1.03)).
Table 2 presents descriptive data of the continuous
variables between early dropouts, late dropouts and
completers. Age, confidence to quit, and smoking history
appeared to vary by withdrawal status; younger people,
those with lower confidence to quit in the next 6 months,
and those with shorter smoking history seemed more
likely to drop out early. There also appeared to be a
trend for those dropping out early in the study to have
left education later and to have reported lower baseline
expired air CO value than those dropping out later.
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Table 1 Summary of logistic regression analysis for study dropout versus completion
Variable Number Odds ratio (95 % CI)
Methods Trial arma
Intervention 49 1.03 (0.46; 2.32)
Recruitment avenueb
Stop Smoking Services 31 0.81 (0.33; 1.99)
Community 6 0.74 (0.13; 4.35)
Recruitment methodc
Letter plus telephone reminder 38 2.24 (0.95; 5.26)
Community 6 1.12 (0.19; 6.70)
Demographics Age (years) 99 0.97 (0.93; 1.01)
Genderd
Female 56 1.55 (0.68; 3.56)
Body mass index 98 1.01 (0.95; 1.07)
Employment statuse
Unemployed 45 1.13 (0.50; 2.55)
Job statusf
C2-D 45 1.21 (0.27; 5.50)
Unemployed 45 1.33 (0.29; 6.03)
Age left education 99 0.93 (0.73; 1.17)
Smoking-related variables Years smoking 99 0.98 (0.94; 1.01)
Previous use of Stop Smoking Servicesg
Have not used Stop Smoking Services in the past 58 1.14 (0.50; 2.60)
Cigarettes per day 99 1.00 (0.97; 1.03)
Expired air carbon monoxide (parts per million) 98 1.04 (0.99; 1.09)
Fagerström Test for Nicotine Dependence 99 1.19 (0.96; 1.46)
Importance of quitting next 6 months (median)h
High importance 49 1.23 (0.54; 2.76)
Confidence to quit in the next 6 months (median)i
High confidence 48 0.43 (0.19; 0.99)
Confidence to cut down by half in the next month (median)j
High confidence 39 1.44 (0.63; 3.28)
Physical activity-related variables Self-reported ≥30 mins of moderate and vigorous physical activity per dayk
Yes 65 0.48 (0.20; 1.12)
Self-reported minutes of moderate and vigorous physical activity per day 99 1.00 (0.99; 1.00)
Self-reported ≥30 mins moderate and vigorous physical activity on at least 5 daysl
Yes 43 0.77 (0.34; 1.75)
Self-reported ≥150 mins moderate and vigorous physical activity per weekm
Yes 69 0.33 (0.14; 0.81)
Accelerometer ≥30 mins moderate and vigorous physical activity per dayn
Yes 32 1.11 (0.42; 2.95)
Accelerometer minutes moderate and vigorous physical activity per day 66 1.00 (0.98; 1.02)
Stage of change to use physical activity to control smokingo
Planning, action, maintenance 20 0.42 (0.15; 1.40)
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The odds of participant dropout late in the study (ver-
sus completion) were increased for those recruited via
follow-up telephone calls (Table 3). Greater confidence
to quit in the next 6 months was associated with lower
odds of late dropout versus completion compared with
lower confidence. With increasing age, the odds of early
dropout versus completion were reduced, but age did
not appear to be associated with odds of late dropout
versus completion; years of smoking showed a similar
association with both early and late dropout versus com-
pletion. Those who reported doing 150 mins or more of
MVPA per week at baseline had lower odds of early
dropout compared with participants who did not
complete at least 150 mins of MVPA per week; however,
no equivalent association was found with regard to late
dropout.
Variables shown to be related to attrition in the uni-
variable multinomial analyses were carried forward into
a multivariable multinomial analysis and are show in
Table 4. Only the completion of 150 mins of MVPA per
week or more retained any significance in the presence
of the other variables, with those completing more than
150 mins of MVPA per week at baseline being less likely
to drop out early than later in the study when compared
to study completers.
Exploratory analyses of change in cigarettes smoked
per day (from baseline to either week 4 or week 8),
shown in Table 5, showed no significance in predicting
study dropout before week 16.
Qualitative reasons for dropout were not possible to
obtain directly from participants whom we were unable
to contact. Of those who explicitly withdrew consent
(n = 15), the reasons for dropout included illness or
death of a close family member, advice from a mental
health care worker that the participant had become
anxious about involvement in the study, time pressures
Table 1 Summary of logistic regression analysis for study dropout versus completion (Continued)
Confidence to exercise for ≥30 mins on most days over next 6 monthsp
High confidence 55 0.83 (0.37; 1.86)
Confidence to walk for ≥15 mins at a brisk paceq
High confidence 59 1.06 (0.47; 2.43)
Indicated mental health problemr
Yes 41 1.49 (0.65; 3.38)
aReference: control; bReference: primary care; cReference: letter only; dReference: male; eReference: employed; fReference: social class A–C1; gReference: have used
SSS in the past; hReference: low importance; iReference: low confidence; jReference: low confidence; kReference: not reporting 30 mins MVPA per day; lReference:
not completing 30 mins MVPA on at least 5 days per week; mReference: not reporting >150 mins MVPA per week; nReference: not completing 30 mins MVPA per
day as assessed by accelerometer; oReference: pre-contemplation and contemplation; pReference: low confidence; qReference: low confidence; rReference group: no
indicated mental health problem
Table 2 Comparison of continuous baseline variables by early dropouts, late dropouts, and study completers
Number Early dropout (before week
4)
Late dropout (after week
4)
Completer
Age; mean (SD), n 99 40.9 (10.2), 21 48.2 (10.7), 17 48.1 (11.4), 61
Age left education; mean (SD); median (IQR), n 99 16.5 (1.3); 16 (16; 17), 21 15.7 (0.9); 15 (15; 16), 17 16.4 (2.2); 16 (15;16)
BMI; mean (SD); median (IQR), n 98 29.0 (7.9); 28.0 (23.2; 33.3),
21
27.5 (5.7); 27.3 (22.1; 32.6),
17
28.0 (6.0); 27.0 (22.5; 31.7),
60
Years smoking; mean (SD); median (IQR), n 99 25.3 (11.9); 27.7 (12.6; 31.8),
21
35.2 (11.6); 37.4 (24.6; 44.7),
17
33.3 (11.9); 35.8 (23.4; 43.1),
61
CPD; mean (SD); median (IQR), n 99 19.2 (7.6); 19.8 (13.3; 27.8),
21
23.7 (21.2); 19.6 (15.0; 27.8),
17
21.8 (13.8); 18.9 (15.0; 23.9),
61
CO; mean (SD); median (IQR), n 98 17.9 (10.0); 14 (11; 21), 21 21.6 (5.2); 21.5 (17.5; 24), 16 17.1 (7.8); 16 (12; 22), 61
FTND; mean (SD), n 99 5.7 (1.8), 21 6.4 (2.2), 17 5.3 (2.1), 61
Self-reported MVPA per day; mean (SD); median
(IQR), n
99 72.3 (91.0); 42.1 (0; 109.3),
21
43.33 (49.3); 34.3 (0; 111.4),
17
81.0 (98.6); 47.1 (77.1; 25.7),
61
Accelerometer MVPA; mean (SD); median (IQR), n 66 29.3 (20.4); 27.6 (13.2; 42.5),
19
41.3 (32.8); 35.3 (16.3; 44.9),
9
31.0 (24.3); 25.8 (11.8; 43.7),
38
Importance of quitting in next 6 months; mean (SD);
median (IQR), n
99 5.4 (1.5); 6 (4;7), 21 5.1 (2.0); 6 (4;7), 17 5.3 (1.7); 5 (5; 7), 61
Confidence to quit in next 6 months; mean (SD), n 97 3.1 (1.4), 21 2.7 (1.5), 17 3.9 (1.7), 59
SD standard deviation, IQR interquartile range, BMI body mass index, CPD cigrettes per day , CO carbon monoxide, FTND Fagerström Test for Nicotine
Dependence, MVPA moderate and vigorous physical activity
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Table 3 Summary of multinomial logistic regression analysis for study completion status: late/early dropout versus completion
Early dropouts (before week 4) Late dropouts (after week 4)





Intervention 9 0.78 (0.29; 2.10) 10 1.43 (0.50; 4.39)
Recruitment Recruitment avenueb
Stop Smoking Services 6 0.79 (0.26; 2.39) 5 0.84 (0.26; 2.77)
Community 1 0.66 (0.07; 6.42) 1 0.84 (0.08; 8.33)
Recruitment methodc
Telephone 9 1.63 (0.58; 4.62) 10 3.32 (1.05; 10.60)
Community 1 0.86 (0.87; 8.58) 1 1.58 (0.15; 16.61)
Demographics Age (years) 21 0.94 (0.90; 0.99) 17 1.00 (0.95; 1.05)
Genderd
Female 13 1.48 (0.53; 5.05) 11 1.67 (0.54; 5.05)
Body mass index 21 1.02 (0.95; 1.11) 17 0.99 (0.33; 1.08)
Employment statuse
Unemployed 7 0.63 (0.22; 1.79) 11 2.32 (0.76; 7.03)
Job statusf
C2-E 13 2.77 (0.30; 25.53) 4 0.43 (0.06; 2.92)
Unemployed 7 1.55 (0.16; 15.18) 11 1.22 (0.21; 7.03)
Age left education 21 1.04 (0.82; 1.31) 17 0.64 (0.36; 1.14)
Smoking history Years smoking 0.95 (0.90; 0.99) 1.16 (0.97; 1.06)
Previous use of Stop Smoking Servicesg
No 14 01.49 (0.53; 4.22) 9 0.84 (0.28; 2.46)
Smoking-related
variables
Cigarettes per day 21 0.82 (0.94; 1.03) 17 1.01 (0.97; 1.04)
Expired air carbon monoxide (parts per million) 21 1.01 (0.95; 1.08) 16 1.07 (1.00; 1.14)
Fagerstrom Test for Nicotine Dependence 21 1.01 (0.86; 1.42) 17 1.31 (0.98; 1.73)
Importance of quitting in the next 6 months (median)h
High 6–7 11 1.21 (0.45; 3.29) 9 1.24 (0.42; 3.63)
Confidence to quit in the next 6 months (median)i
High 4–7 12 0.55 (0.20; 1.51) 10 0.31 (0.95; 0.98)
Confidence to cut down by half in the next month (median)j
High 5–7 3 1.95 (0.71; 5.31) 2 0.97 (0.31; 2.97)
Physical activity-
related variables
Self-reported ≥30 mins of moderate and vigorous physical activity per dayk
Yes 11 0.42 (0.15; 1.19) 10 0.55 (0.18; 1.68)
Self-reported minutes of moderate and vigorous physical activity per day 21 1.00 (0.99; 1.00) 17 0.99 (0.98; 1.00)
Self-reported ≥30 mins of moderate and vigorous physical activity on at least 5 daysl
Yes 9 0.89 (0.33; 2.41) 6 0.64 (0.21; 1.95)
Self-reported ≥150 mins of moderate and vigorous physical activity per weekm
Yes 11 0.30 (0.10; 0.85) 10 0.39 (0.12; 1.21)
Accelerometer ≥30 mins of moderate and vigorous physical activity per dayn
Yes 8 0.81 (0.27; 2.46) 6 2.23 (0.48; 10.18)
Accelerometer total minutes of moderate and vigorous physical
activity per day
19 1.00 (0.97; 1.02) 9 0.54 (0.99; 1.04)
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elsewhere, expecting a greater financial reward for tak-
ing part (indicating a possible misunderstanding of
study procedures due to poor explanation), and being
dissatisfied with allocation to the control condition.
Discussion
The overall attrition rate of 38.4 % at 16 weeks falls
within the range of attrition rates identified in other
broader trials of smoking cessation. In the absence of
similar studies, the overall retention in this study could
be regarded as acceptable for a group of disadvantaged
smokers and provides valuable information for a larger
study. Unlike some trials, we did not explicitly pay par-
ticipants to complete follow-up assessments and one
may assume a lower attrition rate had we done so.
The fact that over 50 % of those dropping out did so
before week 4 suggests that particular focus is needed
on new ways to maintain participation in the initial
stages of trial engagement. Although attrition in both
treatment arms was the same in the present study, it
may be that the predictors of attrition may vary between
arms. However, the numbers in this pilot trial were in-
sufficient to inferentially test this hypothesis.
The only trial design factors to influence attrition was
whether or not participants were recruited by follow-up
telephone call; those recruited by this more intensive ap-
proach were more likely to drop out later than earlier in
the study, possibly reflecting ambivalence to the invita-
tion. We deliberately conducted follow-up telephone
calls to recruit smokers in case they had low literacy
levels. It may be that providing further data after base-
line was too challenging and we should consider provid-
ing more support to keep these individuals in the study.
Recruitment via different locations (primary care versus
SSS), and the method of recruitment, also showed no ef-
fect on attrition in the sample as a whole. We found
equal attrition in both the intervention and control
arms, which has been reported elsewhere [43].
The mean age of those dropping out early in the study
was younger than the mean age of those completing the
study. Age has been reported elsewhere to predict attri-
tion, with older participants less likely to drop out [57],
suggesting they may be more committed and able to
Table 3 Summary of multinomial logistic regression analysis for study completion status: late/early dropout versus completion
(Continued)
Stage of change to use physical activity to control smokingo
Planning, action, maintenance 2 0.32 (0.07; 1.55) 3 0.66 (0.17; 2.61)
Confidence to exercise for ≥30 mins on most days over next 6 monthsp
High (6–7) 12 0.99 (0.36; 2.69) 8 0.66 (0.23; 1.93)
Confidence to walk for ≥15 mins at a brisk paceq
High (7) 12 0.46 (0.34; 2.53) 11 1.27 (0.41; 3.90)
Indicated mental health problemr
Yes 11 1.82 (0.67; 4.95) 7 1.16 (0.39; 3.46)
aReference: control; bReference: primary care; cReference: letter only; dReference: male; eReference: employed; fReference: social class A-C1; gReference: have used
SSS in the past; hReference: low importance; iReference: low confidence; jReference: low confidence; kReference: not reporting 30 mins MVPA per day;
lReference: not completing 30 mins MVPA on at least 5 days per week; mReference: not reporting >150 mins MVPA per week; nReference: not completing 30 mins
MVPA per day as assessed by accelerometer; oReference: pre-contemplation and contemplation; pReference: low confidence; qReference: low confidence; rReference
group: no indicated mental health problem
Table 4 Multivariable multinomial logistic regression for study completion status: late/early dropout versus completion (N = 97)
Early dropouts (before week 4) Late dropouts (after week 4)
Variable Number Odds ratio (95 % CI) Number Odds ratio (95 % CI)
Self-reported ≥150 minutes of moderate and vigorous physical activity per weekm
Yes 11 0.23 (0.07; 0.75) 10 0.52 (0.14; 1.90)
Confidence to quit in the next 6 months (median)i
High (4–7) 9 0.50 (0.16; 1.51) 5 0.37 (0.11; 1.27)
Recruitment methodc
Telephone 9 1.25 (0.39; 4.01) 10 2.77 (0.79; 9.78)
Community 1 0.51 (0.42; 6.17) 1 1.72 (0.14; 21.33)
Age (years) 21 1.00 (0.85; 1.17) 17 0.84 (0.65; 1.06)
Years smoking 21 0.94 (0.81; 1.09) 17 1.21 (0.95; 1.54)
aReference: not reporting >150 minutes MVPA per week; bReference: low confidence; cReference: letter only
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have more time to remain in a trial [1]. This highlights
the need for additional support for engaging younger
people. However, other studies have not found age to be
related to attrition [9, 50]. No other participant demo-
graphic characteristics showed evidence of any relation-
ship with study attrition. Our researchers worked
flexible hours to conduct assessments with participants
(in employment or not), and this may have reduced the
risk of attrition.
We were interested in whether we could retain more
dependent and heavier smokers in the trial. The finding
that those with a longer smoking history and a trend for
smoking more cigarettes were more likely to complete
the study was encouraging. They may suggest that a trial
focused on cutting down may be more appealing to
heavier smokers, a finding reported elsewhere [58]. In
contrast it appeared that those with greater confidence
to quit (normally associated with lower dependence)
were less likely to withdraw, specifically, less likely to
withdraw later in the study. These preliminary contrast-
ing findings are not easy to explain but it would appear
that future researchers should stress that smoking be-
haviour and related beliefs (such as confidence to quit)
should not influence continued participation in a trial.
In smoking cessation studies, smoking relapse is typic-
ally associated with attrition and, similarly, it may be
that a failure to reduce smoking levels is associated with
attrition. Also, several of the variables shown to predict
attrition in the present study are the same as those that
predict smoking relapse (e.g. low self-efficacy, lower age)
and there may be a common set of variables that predict
smoking relapse, failure to reduce and attrition. There
may also be variables that are specific to smoking reduc-
tion versus cessation studies. For example, a higher level
of cigarette dependence reliably predicts smoking relapse
[59] but in the current study higher dependence was as-
sociated with less attrition.
Those who completed at least 150 mins of MVPA per
week at baseline were also less likely to withdraw than
those reporting less activity; specifically, these partici-
pants were less likely to withdraw early in the study.
This finding remained significant even in the presence of
other predictor variables in the multivariable model.
This replicates the findings from another study in which
those who were inactive at baseline were significantly
more likely to drop out of an arm of a trial with a focus
on fitness training [60]. Greater study attrition among
less active participants in a physical activity study has
the potential to reduce the size of effects due to a ceiling
effect. It also poses a threat to external validity if the
findings cannot be generalised to less active populations.
Other research involving low socioeconomic groups on
the effectiveness of a physical activity intervention [60]
reported that attrition rates were significantly higher in
those randomised to a ‘fitness assessment’ intervention
compared with an ‘exercise consultation’ intervention.
This suggests that intervention content may differen-
tially influence attrition. The present study involved
physical activity (PA) counselling (as opposed to an em-
phasis on ‘fitness’) and this may have helped to increase
study retention. Avoiding an emphasis on ‘fitness’ may
have helped to maximise external validity by engaging
with and retaining both those who are and are not
already physically active. However, the current study en-
gaged with a comparatively active sample (potentially
due to self-selection), meaning analyses may be less
likely to show an effect (due to a ceiling effect). It also
limits the application of the findings to a more general,
less active, population. The levels of self-reported phys-
ical activity were not corroborated by objective activity
measurement at baseline (accelerometer) and due to the
low numbers and variance in self-reported physical ac-
tivity, more research is needed to further explore if base-
line physical activity influences study attrition.
Failure or success to reduce the amount of cigarettes
smoked between baseline and week 8 showed no confi-
dence in predicting dropout before week 16. This is
likely limited by the lack of precision due to the small
sample size, as the trend was in favour of those who
achieved a reduction in cigarettes smoked before week
16 to demonstrate lower odds of withdrawal, as might
be expected.
The present exploratory study had several limitations.
Due to the relatively low numbers involved in this pilot
trial (and as a result the low number of observations of
the outcome of interest), some caution should be used
in interpreting the findings due to their imprecision.
Nevertheless, we have identified how the findings may
influence planning a larger study, and further such ana-
lysis should be considered in any future larger study to
estimate bias from missing data and study attrition.
The study was also limited in the ethnic diversity of
the sample, with 97 % reporting being white British,
which is typical of the geographical area in which the
study was located. This limits the findings to other more
ethnically diverse populations and is something that
would need to be considered carefully in future research
Table 5 Logistic regression of study attrition for change in
cigarettes smoked per day before week 16 (N = 78)
(late dropout versus completion)
Variable Number Odds ratio (95 % CI)
Reduction of 50 % or more before week 16
Yes 28 0.31 (0.08; 1.19)
Any reduction in cigarettes smoked per day before week 16
Yes 58 0.55 (0.17; 1.74)
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(as ethnicity is something that has been found to be pre-
dictive of dropout in other studies [1]).
We chose not to incentivise data capture to avoid the
potential of influencing trial outcomes in this pragmatic
study. Preliminary work also revealed that financial in-
centive was treated with caution by some participants
for fear of jeopardising government unemployment ben-
efits. The payment for returning an accelerometer was
implemented in an attempt to minimise the loss of ex-
pensive equipment and not as an incentive for participa-
tion, although it may have acted as such. Incentivisation
could be considered for future research in more detail.
Conclusions
The present research provides important information on
factors that may influence attrition within a multi-
component smoking reduction study among low socioeco-
nomic status smokers. Retention was at least comparable
with the few other studies involving disadvantaged groups
with smoking behaviour as a main outcome. These ana-
lyses provide unique information on retention in a study
aimed at smokers in these groups who did not wish to
quit. Only a few factors were quantitatively associated with
attrition, suggesting that further research is needed to
explain why participants in this type of study drop out.
Qualitatively, the diverse reasons for study attrition ap-
peared to be mainly due to unpredictable participant life
events and perhaps a misunderstanding about trial
involvement.
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